Clinical Trial Update: A Study of SAL003 in Participants With Hypercholesterolemia and Mixed Dyslipidemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial SAL003 in hypercholesterolemia and mixed dyslipidemia has completed enrollment and status is updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hypercholesterolemia

Drugs mentioned

• SAL003

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Hyperlipidemias | Phase 3 | Status: COMPLETED